Global Assisted Reproductive Technology Market
HealthcareServices

Global Assisted Reproductive Technology Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Assisted Reproductive Technology Industry In 2025?

The assisted reproductive technology market has experienced robust expansion in recent years. It is projected to grow from $34.35 billion in 2024 to $37.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.9%. Historically, this market’s growth can be attributed to an increase in infertility rates, changing societal norms, growing awareness, legislative support, and an aging population.

The assisted reproductive technology market size is projected to experience robust expansion over the coming years. This market is anticipated to reach a value of $52.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. Several factors contribute to this growth during the forecast period, including the growing maternal age, an increased desire for same-sex parenting, the rise of medical tourism, improvements in healthcare infrastructure, and advancements in research and development. Key developments expected within this period encompass the application of artificial intelligence (AI), the practice of egg freezing, single-embryo transfer (SET), PGT-A and genetic screening, alongside new fertility preservation methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Which Major Market Drivers Are Shaping The Future Of The Assisted Reproductive Technology Market?

The increasing incidence of infertility is projected to stimulate the assisted reproductive technology market in the foreseeable future. Infertility is characterized as the inability to conceive following twelve months of regular, unprotected sexual activity. This condition impacts both genders and is commonly identified through the failure to achieve pregnancy. Treatment for infertility often involves the use of assisted reproductive technology (ART). These therapies encompass methods that involve both female ova and male spermatozoa. For example, data from April 2023 released by the World Health Organization (WHO), an international public health body headquartered in Switzerland, indicates that millions globally of reproductive age face challenges with infertility, impacting their families and communities. Globally, approximately 1 in 6 adults, or about 17.5% of the adult population worldwide, are estimated to experience infertility. Consequently, the growing prevalence of infertility cases propels the expansion of the assisted reproductive technology market.

What Are The Major Segment Types Covered In The Assisted Reproductive Technology Market?

The assisted reproductive technologymarket covered in this report is segmented –

1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing

2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking

3) By End-User: Hospitals; Fertility Clinics; Other End-Users

Subsegments:

1) By Ovulation Testing: Urine Ovulation Predictor Kits; Saliva Ovulation Test Kits

2) By Hysterosalpingography (HSG): X-ray HSG; Sonohysterography (SHG)

3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing; Anti-Müllerian Hormone (AMH) Testing; Antral Follicle Count (AFC) via Ultrasound

4) By Genetic Testing: Preimplantation Genetic Testing (PGT); Carrier Screening Tests; Genetic Compatibility Testing

What Trends Are Redefining The Assisted Reproductive Technology Market Dynamics?

Technological advancements stand out as a key trend gaining significant traction in the assisted reproductive technology market. Major companies operating in the assisted reproductive technology sector are dedicating efforts to developing technological solutions to strengthen their market standing. For instance, in October 2022, Alife Health, a US-based medical equipment manufacturing company, launched its Alife Assist platform. This suite of products is engineered to transform the in-vitro fertilization (IVF) process by leveraging data-driven insights and artificial intelligence (AI) to support clinical decision-making during critical IVF phases and to optimize the operations of fertility clinics. This innovative platform, which comprises Stim Assist, Embryo Assist, and Insights, provides comprehensive assistance to reproductive endocrinologists, embryologists, and clinic administrators, thereby improving medication dosing, embryo grading, and real-time performance monitoring, ultimately enhancing the patient experience and success rates in IVF procedures.

Which Key Players Are Driving Competition In The Assisted Reproductive Technology Market?

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

What Regional Growth Trends Are Shaping The Assisted Reproductive Technology Market Outlook?

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Assisted Reproductive Technology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2025, By The Business Research Company

Prenatal Testing And Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Fertility Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model